• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利：CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法，用中文像聊天一样搜索，搜遍4000万医学文献。AI智能推荐，让科研检索更轻松。

立即免费搜索

文件翻译

保留排版，准确专业，支持PDF/Word/PPT等文件格式，支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述，25分钟生成高质量综述，智能提取关键信息，辅助科研写作。

立即免费体验

Haploidentical allogeneic hematopoietic stem cell transplantation in patients with high-risk soft tissue sarcomas: results of a single-center prospective trial.

作者信息

Merker Michael, Meister Michael Torsten, Rettinger Eva, Jarisch Andrea, Soerensen Jan, Willasch Andre, Huenecke Sabine, Cappel Claudia, Bremm Melanie, Salzmann-Manrique Emilia, Krenn Thomas, Rossig Claudia, Kremens Bernhard, Koscielniak Ewa, Klingebiel Thomas, Bader Peter

机构信息

Division of Stem Cell Transplantation and Immunology, Department of Children and Adolescents, University Hospital Frankfurt, Goethe University, Frankfurt/Main, Germany.

Department of Pediatric Oncology and Hematology, Saarland University Hospital, Homburg/Saar, Germany.

出版信息

Bone Marrow Transplant. 2018 Jul;53(7):891-894. doi: 10.1038/s41409-018-0088-6. Epub 2018 Jan 24.

DOI:10.1038/s41409-018-0088-6
PMID:29367709
Abstract
摘要

相似文献

1
Haploidentical allogeneic hematopoietic stem cell transplantation in patients with high-risk soft tissue sarcomas: results of a single-center prospective trial.单倍体相合异基因造血干细胞移植治疗高危软组织肉瘤患者：单中心前瞻性试验结果
Bone Marrow Transplant. 2018 Jul;53(7):891-894. doi: 10.1038/s41409-018-0088-6. Epub 2018 Jan 24.
2
Medication adherence among allogeneic hematopoietic stem cell transplant recipients: a pilot single-center study.异基因造血干细胞移植受者的药物依从性：一项单中心试点研究。
Bone Marrow Transplant. 2018 Feb;53(2):231-233. doi: 10.1038/bmt.2017.233. Epub 2017 Nov 20.
3
Post-transplantation Cyclophosphamide and Sirolimus after Haploidentical Hematopoietic Stem Cell Transplantation Using a Treosulfan-based Myeloablative Conditioning and Peripheral Blood Stem Cells.使用白消安为基础的清髓性预处理方案及外周血干细胞进行单倍体相合造血干细胞移植后环磷酰胺和西罗莫司的应用
Biol Blood Marrow Transplant. 2015 Aug;21(8):1506-14. doi: 10.1016/j.bbmt.2015.04.025. Epub 2015 May 19.
4
Donor-derived constitutional chromosomal abnormalities after allogeneic hematopoietic cell transplantation: a single-center experience and a review of the literature.异基因造血细胞移植后供者来源的染色体结构异常：单中心经验及文献综述
Bone Marrow Transplant. 2015 Oct;50(10):1388-92. doi: 10.1038/bmt.2015.168. Epub 2015 Jul 20.
5
Hematopoietic stem cell transplantation in geriatric patients in Turkey.土耳其老年患者的造血干细胞移植
Transfus Apher Sci. 2018 Apr;57(2):159-162. doi: 10.1016/j.transci.2018.04.013. Epub 2018 Apr 18.
6
Time-to-Event Ratio to Predict Outcome in Patients with Acute Myeloid Leukemia Undergoing Allogeneic Hematopoietic Cell Transplantation?用于预测接受异基因造血细胞移植的急性髓系白血病患者预后的事件发生时间比？
Biol Blood Marrow Transplant. 2017 Oct;23(10):1804-1808. doi: 10.1016/j.bbmt.2017.06.016. Epub 2017 Jul 5.
7
Consensus Opinion on Allogeneic Hematopoietic Cell Transplantation in Advanced Systemic Mastocytosis.晚期系统性肥大细胞增多症异基因造血细胞移植的共识意见
Biol Blood Marrow Transplant. 2016 Aug;22(8):1348-1356. doi: 10.1016/j.bbmt.2016.04.018. Epub 2016 Apr 27.
8
Prognostic Scoring Systems in Allogeneic Hematopoietic Stem Cell Transplantation: Where Do We Stand?异基因造血干细胞移植中的预后评分系统：我们处于什么位置？
Biol Blood Marrow Transplant. 2017 Nov;23(11):1839-1846. doi: 10.1016/j.bbmt.2017.07.028. Epub 2017 Aug 7.
9
Getting fit for allogeneic hematopoietic cell transplantation.为异基因造血细胞移植做好准备。
Bone Marrow Transplant. 2014 Oct;49(10):1249-50. doi: 10.1038/bmt.2014.160. Epub 2014 Jul 28.
10
Lineage-specific chimerism monitoring after allogeneic haematopoietic stem cell transplantation: do we really know what we are measuring?异基因造血干细胞移植后的谱系特异性嵌合体监测：我们真的知道自己在测量什么吗？
Br J Haematol. 2017 Jan;176(1):139-141. doi: 10.1111/bjh.13935. Epub 2016 Feb 5.

引用本文的文献

1
Pediatric Patients with Stage IV Rhabdomyosarcoma Significantly Benefit from Long-Term Maintenance Therapy: Results of the CWS-IV 2002 and the CWS DOK IV 2004-Trials.IV期横纹肌肉瘤患儿从长期维持治疗中显著获益：CWS-IV 2002和CWS DOK IV 2004试验结果
Cancers (Basel). 2023 Mar 30;15(7):2050. doi: 10.3390/cancers15072050.
2
Haploidentical hematopoietic stem cell transplantation as individual treatment option in pediatric patients with very high-risk sarcomas.单倍体相合造血干细胞移植作为高危小儿肉瘤患者的个体化治疗选择
Front Oncol. 2023 Feb 21;13:1064190. doi: 10.3389/fonc.2023.1064190. eCollection 2023.
3
No Improvement of Survival for Alveolar Rhabdomyosarcoma Patients After HLA-Matched Versus -Mismatched Allogeneic Hematopoietic Stem Cell Transplantation Compared to Standard-of-Care Therapy.
与标准治疗相比，HLA匹配与不匹配的异基因造血干细胞移植后，肺泡横纹肌肉瘤患者的生存率无改善。
Front Oncol. 2022 May 10;12:878367. doi: 10.3389/fonc.2022.878367. eCollection 2022.
4
Retargeting of NK-92 Cells against High-Risk Rhabdomyosarcomas by Means of an ERBB2 (HER2/Neu)-Specific Chimeric Antigen Receptor.通过ERBB2（HER2/Neu）特异性嵌合抗原受体将NK-92细胞重新靶向高危横纹肌肉瘤。
Cancers (Basel). 2021 Mar 22;13(6):1443. doi: 10.3390/cancers13061443.
5
ERBB2-CAR-Engineered Cytokine-Induced Killer Cells Exhibit Both CAR-Mediated and Innate Immunity Against High-Risk Rhabdomyosarcoma.工程化 ERBB2-CAR 细胞因子诱导的杀伤细胞对高危横纹肌肉瘤表现出 CAR 介导的和固有免疫双重作用。
Front Immunol. 2020 Oct 19;11:581468. doi: 10.3389/fimmu.2020.581468. eCollection 2020.
6
Current and Future Treatment Strategies for Rhabdomyosarcoma.横纹肌肉瘤的当前及未来治疗策略
Front Oncol. 2019 Dec 20;9:1458. doi: 10.3389/fonc.2019.01458. eCollection 2019.
7
The Synergistic Use of IL-15 and IL-21 for the Generation of NK Cells From CD3/CD19-Depleted Grafts Improves Their Expansion and Cytotoxic Potential Against Neuroblastoma: Perspective for Optimized Immunotherapy Post Haploidentical Stem Cell Transplantation.IL-15 和 IL-21 的协同作用可从 CD3/CD19 depleted 移植物中生成 NK 细胞，从而增强其扩增和对神经母细胞瘤的细胞毒性潜力：对单倍体造血干细胞移植后优化免疫治疗的展望。
Front Immunol. 2019 Dec 3;10:2816. doi: 10.3389/fimmu.2019.02816. eCollection 2019.
8
Adoptive cellular immunotherapy for refractory childhood cancers: a single center experience.难治性儿童癌症的过继性细胞免疫治疗：单中心经验
Oncotarget. 2019 Oct 22;10(58):6138-6151. doi: 10.18632/oncotarget.27242.